HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fanfan Zhou Selected Research

Organic Anion Transporters

1/2010Functional characterization of nonsynonymous single nucleotide polymorphisms in the human organic anion transporter 4 (hOAT4).
7/2007Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells.
1/2007Molecular insights into the structure-function relationship of organic anion transporters OATs.
4/2006Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells.
9/2005Human organic anion transporter hOAT1 forms homooligomers.
7/2004Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fanfan Zhou Research Topics

Disease

23Neoplasms (Cancer)
08/2022 - 07/2004
7Breast Neoplasms (Breast Cancer)
01/2022 - 08/2012
7Mitochondrial Diseases (Mitochondrial Disease)
09/2021 - 03/2014
6Inflammation (Inflammations)
08/2022 - 04/2010
6Neuroblastoma
09/2021 - 01/2014
6Retinoblastoma (Glioblastoma, Retinal)
02/2021 - 01/2018
5Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021 - 01/2014
4Neoplasm Metastasis (Metastasis)
08/2022 - 05/2016
4Infections
02/2022 - 04/2010
4Necrosis
01/2022 - 01/2019
4Carcinogenesis
01/2022 - 08/2012
4Macular Degeneration (Age-Related Maculopathy)
10/2018 - 10/2016
3Uveal melanoma
08/2022 - 01/2022
3Retinal Diseases
06/2021 - 10/2019
3Leukostasis
10/2017 - 01/2014
2Melanoma (Melanoma, Malignant)
01/2022 - 11/2021
2Rheumatoid Arthritis
08/2021 - 08/2020
2Respiratory Tract Infections (Respiratory Tract Infection)
08/2020 - 10/2019
2Diabetic Retinopathy (Retinopathy, Diabetic)
10/2019 - 01/2014
2Hypoxia (Hypoxemia)
01/2019 - 04/2010
2Carcinoma (Carcinomatosis)
05/2016 - 08/2013
2Alzheimer Disease (Alzheimer's Disease)
01/2015 - 03/2014
1Hyperglycemia
08/2022
1Triple Negative Breast Neoplasms
01/2022
1Monosomy
11/2021
1Glaucoma
10/2019
1Non-alcoholic Fatty Liver Disease
12/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2018

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
05/2022 - 07/2012
6Anti-Bacterial Agents (Antibiotics)IBA
03/2018 - 07/2004
6Organic Anion TransportersIBA
01/2010 - 07/2004
5Glutamic Acid (Glutamate)FDA Link
01/2022 - 01/2016
5Antihypertensive Agents (Antihypertensives)IBA
07/2007 - 07/2004
5Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2007 - 07/2004
3Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2015
3Polymyxins (Polymyxin)IBA
02/2022 - 02/2016
3Retinaldehyde (Retinal)IBA
10/2018 - 01/2014
3Neuroprotective AgentsIBA
05/2016 - 01/2015
3Ciliary Neurotrophic Factor (CNTF)IBA
01/2015 - 01/2014
2Phosphotransferases (Kinase)IBA
08/2022 - 08/2013
2procyanidin B2IBA
08/2022 - 01/2021
2Carrier Proteins (Binding Protein)IBA
11/2021 - 01/2010
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2021 - 09/2015
2Colistin (Coly-Mycin)FDA Link
08/2020 - 10/2019
2Ciprofloxacin (Cipro)FDA LinkGeneric
08/2020 - 10/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 09/2015
2peoniflorinIBA
10/2018 - 03/2014
2Transcription Factors (Transcription Factor)IBA
09/2018 - 09/2016
2Thymidine Monophosphate (TMP)IBA
10/2017 - 09/2015
2Amyloid (Amyloid Fibrils)IBA
06/2017 - 01/2017
2puerarinIBA
01/2016 - 01/2014
2alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
01/2015 - 01/2014
2ziyuglycoside IIIBA
05/2014 - 09/2013
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2014 - 08/2013
2Sorafenib (BAY 43-9006)FDA Link
08/2013 - 07/2012
1AfatinibIBA
08/2022
1Caveolin 1IBA
08/2022
1Cytotoxins (Cytolysins)IBA
01/2022
1Drug CombinationsIBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022
1ixabepilone (BMS 247550)FDA Link
01/2022
1taxaneIBA
01/2022
1elaiophylinIBA
01/2022
1Sirtuin 1IBA
01/2022
1Guanine NucleotidesIBA
11/2021
1Histone Deacetylase InhibitorsIBA
11/2021
1Therapeutic UsesIBA
09/2021
1Ginkgo biloba extract (Rokan)IBA
09/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2021
1InterleukinsIBA
08/2021
1Dinoprostone (PGE2)FDA Link
08/2021
1Peptide Hydrolases (Proteases)FDA Link
08/2021
1Pentacyclic TriterpenesIBA
06/2021
1tubeimoside IIIBA
02/2021
1Rutin (Rutoside)IBA
01/2021
1AntioxidantsIBA
01/2021
1PowdersIBA
08/2020
1Methotrexate (Mexate)FDA LinkGeneric
08/2020
1Antirheumatic Agents (DMARD)IBA
08/2020
1Liposomes (Liposome)IBA
10/2019
1Annexin A5IBA
10/2019
1cobaltous chloride (cobalt(II)chloride)IBA
01/2019
1Simvastatin (Zocor)FDA LinkGeneric
01/2019
1CalreticulinIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1resazurinIBA
01/2019
1AcidsIBA
01/2019
1AMP-Activated Protein KinasesIBA
12/2018
1Dactinomycin (Actinomycin)FDA LinkGeneric
12/2018
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
10/2018
1Retinal Pigments (Pigments, Visual)IBA
10/2018
1Forkhead Box Protein M1IBA
09/2018
1Carboplatin (JM8)FDA LinkGeneric
09/2018
1Serine (L-Serine)FDA Link
08/2018
1corosolic acidIBA
06/2018

Therapy/Procedure

17Therapeutics
01/2022 - 07/2004
2Drug Therapy (Chemotherapy)
09/2016 - 01/2015
1Immunotherapy
11/2021
1Respiratory Therapy (Therapy, Respiratory)
08/2020